Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
04/2005
04/21/2005CA2539587A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
04/20/2005EP1210330B1 Antibacterial agents
04/20/2005CN1608074A P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
04/20/2005CN1608061A Therapeutic isoquinoline compounds
04/20/2005CN1608052A Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
04/14/2005WO2005033064A1 Process of preparing o-carbamoyl compounds in the presence of active amine group
04/14/2005WO2005032590A1 Remedy for diabetes
04/14/2005WO2004113391A3 Improved pharmaceutical drug candidates and methods for preparation thereof
04/14/2005WO2004103961A3 Sulfated bis-cyclic agents
04/14/2005US20050080271 Peptidomimetic ligands for cellular receptors and ion channels
04/14/2005US20050080268 Process of preparing O-carbamoyl compounds in the presence of active amine group
04/14/2005US20050080267 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
04/14/2005US20050080141 Amino diols useful in the treatment of alzheimer's disease
04/14/2005US20050080127 for the prophylaxis and therapy of osteoarthritis and rheumatism
04/14/2005US20050080119 Diaminopropionic acid derivatives
04/14/2005US20050080077 Serotonin receptor antagonists such as cis-4,N-dimethyl-N-(3-(4-methylpiperidin-1-yl)cyclopentyl)-benzenesulfonamide for treatment of neurological conditions (depression and sleep disorders)
04/14/2005US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators
04/14/2005US20050079541 Immunoadhesin comprising a glycorprotein v1 domain
04/14/2005CA2541303A1 Process of preparing o-carbamoyl compounds in the presence of active amine group
04/14/2005CA2540741A1 Agent for treating diabetes
04/13/2005CN1606431A Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes
04/12/2005US6878706 N-(morpholinocarbonylmethyl)-N-isobutyl(benzylcarbonyl-N -cyanoamino)acetamide; treating rheumatoid arthritis, autoimmune diseases, osteoporosis, asthma, Alzheimer's disease, atherosclerosis and endometriosis.
04/12/2005US6878700 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
04/07/2005WO2005030794A2 Hemiasterlin derivatives and uses thereof
04/07/2005WO2005030791A2 Isoquinolinone potassium channel inhibitors
04/07/2005WO2005030729A1 Isoquinoline potassium channel inhibitors
04/07/2005WO2005030728A1 Bicyclic imino acid derivatives used as inhibitors of matrix-metalloproteinases
04/07/2005WO2005030727A1 Isoquinolinone potassium channel inhibitors
04/07/2005WO2005030726A1 Isoquinolinone potassium channel inhibitors
04/07/2005WO2005030130A2 Isoquinoline potassium channel inhibitors
04/07/2005WO2004014871A8 Vanilloid receptor ligands and their use in treatments
04/07/2005US20050075344 Melanocortin receptor agonists
04/07/2005CA2539823A1 Hemiasterlin derivatives and uses thereof
04/07/2005CA2539731A1 Bicyclic imino acid derivatives used as inhibitors of matrix-metalloproteinases
04/06/2005EP1519972A1 Compositions for producing aminoplast products and method for producing products from these compositions
04/06/2005EP1519921A2 Substituted anthranilic amide derivatives and methods of use
04/06/2005CN1195737C HIV proteinase inhibitor
04/06/2005CN1195514C Metabolites of ecteinascidin 743
04/05/2005US6875765 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family
04/05/2005US6875764 Urea and thiourea compounds useful for treatment of coccidiosis
04/05/2005US6875761 Certain 1,3-disubstituted isoquinoline derivatives
04/05/2005US6875523 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes
03/2005
03/31/2005WO2005028444A1 1,4-disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
03/31/2005WO2005016867A3 Anthranilic acid derivatives and their use as activators of the hm74a receptor
03/31/2005US20050070719 Central nervous system disorders; antidiabetic agents; antiinflammatory agents; antiarthritic agents;obesity; osteoporosis ; anticancer agents
03/31/2005US20050070570 6,8-Dimethoxy isoquinoline derivatives; useful in the treatment or alleviation of disorders and conditions associated with, or dependent on membrane potential or conductance of cells in mammals, including humans, such as asthma, cystic fibrosis, obstructive pulmonary disease, convulsions, vascular spasms
03/31/2005US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response
03/31/2005CA2538855A1 1,4-disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
03/30/2005EP1519192A2 HIV Protease inhibitor conjugates and antibodies useful in ummunoassay
03/30/2005EP1517898A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
03/30/2005EP1517896A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity
03/30/2005EP1517882A1 Amide linker peroxisome proliferator activated receptor modulators
03/30/2005EP1517680A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
03/30/2005CN1602344A Electroluminescent platinum compounds and devices made with such compounds
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/29/2005US6872850 Inhibiting secretion of proteins encoded by adenosine uridylate-rich messenger RNAs, e.g. tumor necrosis factor, interleukin, interferon, cyclooxygenase-1 and -2 by administering a mono- or bisguanylhydrazones
03/24/2005WO2005025681A2 A system for and a method of manufacturing personal golf putters
03/24/2005WO2004072101A3 Phenylglycine derivatives useful as serine protease inhibitors
03/24/2005WO2004064730A3 Compounds, compositions and methods
03/24/2005WO2004060882A8 Cb 1/cb 2 receptor ligands and their use in the treatment of pain
03/24/2005WO2004039795A3 Amide compounds for the treatment of hyperlipidemia
03/24/2005US20050065170 Compounds
03/24/2005US20050065095 Antibacterial agents
03/24/2005CA2482232A1 Protease inhibitor conjugates and antibodies useful in immunoassay
03/23/2005EP1516877A1 Amine derivatives as protease inhibitors
03/23/2005EP1515944A1 Aspartyl protease inhibitors
03/23/2005CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/23/2005CN1193990C Method for synthesizing 1-amino isoquinoline
03/22/2005US6870055 Heterocyclic amides such as 3-dimethylaminomethyl-6-methoxy-2 -methyl-4-phenyl-2H-isoquinoline-1-one, used as antiarrhythmic agents
03/17/2005WO2005023242A1 Entry inhibitors of the hiv virus
03/17/2005WO2003037887A8 Therapeutic isoquinoline compounds
03/17/2005US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor
03/17/2005US20050059662 Substituted quinazolinone compounds
03/16/2005EP1513828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
03/15/2005US6867334 Treating mammalian leukemia; lung carcinoma; colon adenocarcinoma malignant melanoma; assaying the human cytochrome CYP3A4 metabolism of ecteinascidin 743
03/15/2005US6867208 Vitronectin receptor antagonists, their preparation and their use
03/15/2005US6867203 Cinnamide derivatives with aryl sulfide functionality; cerebral vasospasm
03/10/2005WO2005021533A1 Substituted isoquinoline derivatives and methods of use
03/10/2005WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005WO2005020882A2 Compound capable of binding s1p receptor and pharmaceutical use thereof
03/10/2005WO2004112793B1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
03/10/2005WO2002080150A8 Optical data medium containing, in the information layer, a dye as a lightabsorbing compound and having a protective covering layer of predetermined thickness
03/10/2005US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression
03/10/2005US20050054637 Prophylaxis, therapy cardiovascular disorders
03/10/2005CA2824106A1 Compound capable of binding s1p receptor and pharmaceutical use thereof
03/10/2005CA2537093A1 Compound capable of binding s1p receptor and pharmaceutical use thereof
03/10/2005CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/09/2005EP1511770A2 Immunoadhesin comprising a glycoprotein vi domain
03/09/2005EP1511728A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
03/09/2005EP1511727A2 Aromatic sulfones and their medical use
03/09/2005EP1511480A2 Inhibitors of glycoprotein vi
03/09/2005EP1123918B1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same
03/09/2005CN1192022C Novel compound
03/09/2005CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
03/03/2005WO2005019194A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors
03/03/2005US20050049253 Substituted quinolinone derivatives and methods of use
03/03/2005US20050049251 Inhibitors of p38
03/03/2005US20050049240 Tetrahydroisochinolines, their production and the use thereof as analgesics
03/02/2005EP1509504A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
03/02/2005EP1509503A2 Iminium salts in cleaning compositions
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 119